Revelation Biosciences Inc（REVB）價格預測REVBRevelation Biosciences Inc

Alphio's REVB stock price prediction model matches the current Revelation Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.71 (+0.39%). The 1-week path is $3.70 (+0.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Revelation Biosciences Inc is currently not a strong buy due to its ongoing financial losses and recent stock performance. The current price is $3.69, which is significantly down 83.77% year-to-date and 87.31% over the past year. Although the company has a potential total addressable market of $94 billion for its product Gemini, the recent earnings report showed a GAAP EPS of -5.92, indicating continued challenges in profitability. The main risk is the company's high net loss of $59.76 million for FY 2025, which raises concerns about its financial sustainability.

Revelation Biosciences Inc (REVB) last closed at $3.6949999, gaining +3.79%. These facts feed the 1-day and 1-week REVB price prediction above.